Chardan Capital Reaffirms “Buy” Rating for Hyperliquid Strategies (NASDAQ:PURR)

Hyperliquid Strategies (NASDAQ:PURR)‘s stock had its “buy” rating reissued by stock analysts at Chardan Capital in a research report issued on Thursday,Benzinga reports. They currently have a $9.75 price target on the stock. Chardan Capital’s price target would suggest a potential downside of 25.14% from the company’s previous close.

A number of other research analysts also recently issued reports on the stock. Weiss Ratings upgraded shares of Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, June 3rd. Cantor Fitzgerald boosted their price objective on shares of Hyperliquid Strategies from $8.00 to $18.40 and gave the company an “overweight” rating in a research report on Wednesday, July 1st. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $12.72.

Hyperliquid Strategies Trading Up 12.7%

Hyperliquid Strategies stock opened at $13.03 on Thursday. Hyperliquid Strategies has a 12 month low of $3.01 and a 12 month high of $12.54. The stock has a fifty day simple moving average of $7.74. The firm has a market capitalization of $1.88 billion, a P/E ratio of -1.74 and a beta of 1.71.

Hedge Funds Weigh In On Hyperliquid Strategies

Several hedge funds and other institutional investors have recently modified their holdings of PURR. State of Wyoming acquired a new stake in shares of Hyperliquid Strategies in the 2nd quarter worth about $46,000. Shepherd Financial Partners LLC acquired a new position in Hyperliquid Strategies during the 2nd quarter valued at about $79,000. Boothbay Fund Management LLC acquired a new position in Hyperliquid Strategies during the 4th quarter valued at about $40,000. Lotus Technology Management LP acquired a new position in Hyperliquid Strategies during the 2nd quarter valued at about $93,000. Finally, XTX Topco Ltd bought a new position in Hyperliquid Strategies in the 4th quarter worth about $48,000. Institutional investors and hedge funds own 9.45% of the company’s stock.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.